× We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click our cookies policy for information on how to change your cookie settings.


meta|Evidence - COVID-19

Live meta-analysis and evidence synthesis of therapies for COVID19  

tutorial video
En     Fr

Our approach

RSS

enable push notifications

     
Treament Trials
Demonstrated or suggested benefit Inconclusive results Uncertain results Safety results
2 noneinconclusive results for: deaths; clinical deterioration; clinical improvement (14-day); ICU admission--
1

suggested 45 % decrease in deaths

suggested 45 % decrease in deaths (time to event analysis only)

suggested 29 % increase in clinical improvement

suggested 35 % increase in clinical improvement (28-day)

suggested 29 % increase in clinical improvement (time to event analysis only)

suggested 28 % decrease in serious adverse events

inconclusive results for: deep vein thrombosis; elevated liver enzymes; hyperbilirubinemia; pulmonary embolism; renal impairment--
2 noneinconclusive results for: deaths; viral clearance --
0- - - -
1 none---
0- - - -
0- - - -
0- - - -
0- - - -
0- - - -

Statistically conclusive: statistically significant with a strict control of overall risk of type 1 error (statistically demonstrated), does not take into account the risk of bias; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N), Université de Lyon (UdL/Idex), and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

     

- About - Our approach - Credits - RSS Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons